News
One of the few drug trials for a possible long Covid ended in disappointment. But lessons are leading to a second chance.
Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid. advertisement. The Washington Post.
Dr. Iwasaki is internationally recognized for her groundbreaking research on viral pathogenesis, human immunobiology, and post-viral chronic conditions, including Long COVID and COVID-19 ...
A new study in cats with a fatal coronavirus infection suggests stem cell therapy could help tackle the immune damage behind ...
Long Covid remains a major concern for millions worldwide. After an infection caused by the SARS-CoV-2 virus, many individuals continue to experience a wide range of symptoms that disrupt their ...
2d
Good Housekeeping on MSNWhy Doctors Are Calling This Common Medication a "Wonder Drug"Metformin is a safe, effective and cheap, and is showing it has promise for longevity, long Covid, weight control and other ...
The small pilot trial found fecal microbiota transplantation was safe in long-term acute care hospital patients colonized ...
Haroon said the kinds of experimental treatments long COVID patients are seeking at private clinics offering apheresis and anti-clotting drugs should only happen in the context of a clinical trial.
Solve M.E. Selects Simmaron Research As Recipient of ME/CFS Catalyst Award to Accelerate Low-Dose Rapamycin Trial for ME/CFS, Long COVID, and IACCs Provided by PR Newswire Jun 17, 2025, 3:30:00 PM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results